drugset / Trial / NCT02213627
Use of Corifolitropin Alfa in Oocyte Donors
Phase 4
Unknown
300 enrolled
IVI Madrid
Instituto Valenciano de Infertilidad, IVI Alicante · collabInstituto Valenciano de Infertilidad, IVI VALENCIA · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if corifollitropin alfa (long-term gonadotropin administration) is effective in a controlled ovarian stimulation protocol in oocyte donors compared to daily gonadotropin administration (recombinant FSH or HP-hMG)
Timeline
- Start
- 2014-10
- Primary completion
- 2015-09
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Corifollitropin alfa | Protein / enzyme biologic | 100 ug | Subcutaneous |
| Subject | Follitropin beta | Protein / enzyme biologic | 150 iu | — |
| Subject | Menopur | Protein / enzyme biologic | 225 iu | — |